ARCHIVES

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 1 | January 25, 2008

Download PDF Visit The Full Archive

Related Articles

CIS Recompetition Approved, But BSC Delays Decision On Matching Requirement

May 15, 1987

Cancer Control: Incidence, Death Rates Continue To Fall, Annual Reports Says

April 23, 1999

NCI Offers Chlorozotocin

November 18, 1977

In Brief: NCI Will Stop Free Group C distribution Of VP-16 Sept. 1 Unless Bristol Supplies It At No Charge

June 25, 1982

Informatics: Gore Helps NCI Open CGAP Website

August 8, 1997

AACI Statement On Cancer Centers Presented to Reform Task Force

April 9, 1993